l carnitine and kidney disease literature on the treatment of vascular with l-carnitine Frontiers Cardiac metabolic remodelling in chronic – Carnitine Supplementation in Chronic Hemodialysis

Biohybrid hydrogel inhibiting -klotho/HDAC3 axis for hepatocellular carcinoma treatment

By designing intelligent nanocarriers, it will be possible to generate ROS in specific organelles of specific cells with optimal kinetics, thereby maximizing antigen cross-presentation

However, it has limitations with regards to the standardised metrics for the haemodynamic parameters utilised, its diagnostic accuracy is challenged by false positive diagnosis due to confounding factors (e.g

Quantitative behavioral metrics showed that AlCl exposure significantly reduced both total locomotor distance and average swimming speed relative to control larvae (Fig

Furthermore, some research indicates that it may accelerate the recovery process in tendons, ligaments, and bones